Our monthly executive management board (EMB) meeting took place on the 3rd of February 2022. This month the consortium was focused on the analysis of the value chains according to the living labs file defined and on the choice of the value chain products by each country. Furthermore, technical aspects regarding the determination of the BioValue Tool attributes (i.e., utility function, substitutes, etc.) and the data warehouse (DWH) were discussed. Finally, partners were encouraged to accelerate dissemination activities and informed about the ethics and data management seminar on 7th February 2022.
